Chronic Hepatitis with Decompensated Cirrhosis

• CLINICAL_TRIALS trial_result · 2019-02-26
  Clinical Trial Update: Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Adults With Chronic HCV Infection and Decompensated Cirrhosis [Phase 3]

  Phase 3 trial update evaluating sofobuvir/velpatasvir with or without ribavirin for 12 weeks in adults with chronic HCV and decompensated ci…